Immunological Characteristics of Patients Receiving Ultra-Short Treatment for Chronic Hepatitis C
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cellular and Infection Microbiology"
DOI: 10.3389/fcimb.2022.885824
Abstract: Reducing the treatment duration for chronic hepatitis C could be an important tool in the effort to reach the elimination goals set by the World Health Organization. The current challenge is to predict the target… read more here.
Keywords: treatment; short treatment; chronic hepatitis; virological relapse ... See more keywords
Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14061189
Abstract: This study investigated the kinetics in HBsAg and the HBsAg loss rate after entecavir or tenofovir disoproxil fumarate (TDF) cessation in patients with chronic hepatitis B (CHB) who achieved virological suppression after virological relapse without… read more here.
Keywords: kinetics hbsag; entecavir tenofovir; virological relapse; clinical relapse ... See more keywords